{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:40:34Z","timestamp":1779986434738,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12072-025-10841-3","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:51:24Z","timestamp":1751608284000},"page":"1231-1241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Addition of midodrine to albumin reduces the incidence of complications of large-volume paracentesis: an RCT comparing midodrine, terlipressin, and albumin"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-1675","authenticated-orcid":false,"given":"Anand V.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehmat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukriti","family":"Baweja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-5610","authenticated-orcid":false,"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"10841_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/lt.500030613","volume":"3","author":"MR Lucey","year":"1997","unstructured":"Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg. 1997;3:628\u2013637","journal-title":"Liver Transpl Surg"},{"key":"10841_CR2","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jceh.2022.03.002","volume":"12","author":"AV Kulkarni","year":"2022","unstructured":"Kulkarni AV, Rabiee A, Mohanty A. Management of portal hypertension. J Clin Exp Hepatol. 2022;12:1184\u20131199","journal-title":"J Clin Exp Hepatol"},{"key":"10841_CR3","first-page":"164","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Int Ascites Club Hepatol. 1996;23:164\u2013176","journal-title":"Int Ascites Club Hepatol"},{"key":"10841_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14218\/JCTH.2019.00048","volume":"8","author":"AV Kulkarni","year":"2020","unstructured":"Kulkarni AV, Kumar P, Sharma M, Sowmya TR, Talukdar R, Rao PN, et al. Pathophysiology and prevention of paracentesis-induced circulatory dysfunction: a concise review. J Clin Transl Hepatol. 2020;8:42\u201348","journal-title":"J Clin Transl Hepatol"},{"key":"10841_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","volume":"111","author":"A Gin\u00e8s","year":"1996","unstructured":"Gin\u00e8s A, Fern\u00e1ndez-Esparrach G, Monescillo A, Vila C, Dom\u00e8nech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111:1002\u20131010","journal-title":"Gastroenterology"},{"key":"10841_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.50.1.90","volume":"50","author":"R Moreau","year":"2002","unstructured":"Moreau R, Asselah T, Condat B, de Kerguenec C, Pessione F, Bernard B, et al. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Gut. 2002;50:90\u201394","journal-title":"Gut"},{"key":"10841_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2796.2006.01654.x","volume":"260","author":"V Singh","year":"2006","unstructured":"Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, et al. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study. J Internal Med. 2006;260:62\u201368","journal-title":"J Internal Med"},{"key":"10841_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","volume":"21","author":"V Singh","year":"2006","unstructured":"Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol. 2006;21:303\u2013307","journal-title":"J Gastroenterol Hepatol"},{"key":"10841_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","volume":"28","author":"B Appenrodt","year":"2008","unstructured":"Appenrodt B, Wolf A, Gr\u00fcnhage F, Trebicka J, Schepke M, Rabe C, et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int. 2008;28:1019\u20131025","journal-title":"Liver Int"},{"key":"10841_CR10","doi-asserted-by":"crossref","unstructured":"Kulkarni AV, Arab JP, Premkumar M, Ben\u00edtez C, Sowmya TR, Kumar P, Sharma M, et al. Terlipressin has stood the test of time: clinical overview in 2020 and future perspectives. Liver Int 2020.","DOI":"10.1111\/liv.14703"},{"key":"10841_CR11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","volume":"103","author":"V Singh","year":"2008","unstructured":"Singh V, Dheerendra PC, Singh B, Nain CK, Chawla D, Sharma N, et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol. 2008;103:1399\u20131405","journal-title":"Am J Gastroenterol"},{"key":"10841_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jhep.2011.04.027","volume":"56","author":"V Singh","year":"2012","unstructured":"Singh V, Dhungana SP, Singh B, Vijayverghia R, Nain CK, Sharma N, et al. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study. J Hepatol. 2012;56:348\u2013354","journal-title":"J Hepatol"},{"key":"10841_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ygh2.395","volume":"2","author":"AV Kulkarni","year":"2020","unstructured":"Kulkarni AV, Kumar P, Singh S, Sharma M, Talukdar R, Murthy VHV, et al. Prevention of paracentesis-induced circulatory dysfunction\u2014a systematic review and network meta-analysis. GastroHep. 2020;2:92\u2013101","journal-title":"GastroHep"},{"key":"10841_CR14","doi-asserted-by":"crossref","unstructured":"Gow PJ, Ardalan ZS, Vasudevan A, Testro AG, Ye B, Angus PW. Outpatient terlipressin infusion for the treatment of refractory ascites. Off J Am Coll Gastroenterol 2016; 111:1041\u20131042.","DOI":"10.1038\/ajg.2016.168"},{"key":"10841_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MEG.0000000000001950","volume":"34","author":"PJ Gow","year":"2022","unstructured":"Gow PJ, Sinclair M, Thwaites PA, Angus PW, Chapman B, Terbah R, et al. Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis. Eur J Gastroenterol Hepatol. 2022;34:206\u2013212","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10841_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18","journal-title":"BMC Med"},{"key":"10841_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0016-5085(90)91303-N","volume":"98","author":"L Tit\u00f3","year":"1990","unstructured":"Tit\u00f3 L, Gin\u00e8s P, Arroyo V, Planas R, Pan\u00e9s J, Rimola A, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146\u2013151","journal-title":"Gastroenterology"},{"key":"10841_CR18","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397\u2013417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"10841_CR19","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31","journal-title":"Crit Care"},{"key":"10841_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715\u2013735","journal-title":"Hepatology"},{"key":"10841_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/gut.48.3.384","volume":"48","author":"J Cabrera","year":"2001","unstructured":"Cabrera J, Falc\u00f3n L, Gorriz E, Pardo MD, Granados R, Quinones A, et al. Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites. Gut. 2001;48:384\u2013389","journal-title":"Gut"},{"key":"10841_CR22","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1111\/liv.16033","volume":"44","author":"C Vashishtha","year":"2024","unstructured":"Vashishtha C, Bhardwaj A, Jindal A, Kumar M, Sarin SK. Effect of midodrine on HVPG in advanced chronic liver disease and acute-on-chronic liver failure\u2014a pilot study. Liver Int. 2024;44:2714\u20132723","journal-title":"Liver Int"},{"key":"10841_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa2008290","volume":"384","author":"F Wong","year":"2021","unstructured":"Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, et al. Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med. 2021;384:818\u2013828","journal-title":"N Engl J Med"},{"key":"10841_CR24","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41598-022-09505-1","volume":"12","author":"AV Kulkarni","year":"2022","unstructured":"Kulkarni AV, Ravikumar ST, Tevethia H, Premkumar M, Kumar K, Sharma M, et al. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study. Sci Rep. 2022;12:5503","journal-title":"Sci Rep"},{"key":"10841_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/hep.28396","volume":"63","author":"M Cavallin","year":"2016","unstructured":"Cavallin M, Piano S, Romano A, Fasolato S, Frigo AC, Benetti G, et al. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study. Hepatology. 2016;63:983\u2013992","journal-title":"Hepatology"},{"key":"10841_CR26","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391:2417\u20132429","journal-title":"Lancet"},{"key":"10841_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.13968","volume":"39","author":"M Di Pascoli","year":"2019","unstructured":"Di Pascoli M, Fasolato S, Piano S, Bolognesi M, Angeli P. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. Liver Int. 2019;39:98\u2013105","journal-title":"Liver Int"},{"key":"10841_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa2022166","volume":"384","author":"L China","year":"2021","unstructured":"China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, et al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384:808\u2013817","journal-title":"N Engl J Med"},{"key":"10841_CR29","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","volume":"69","author":"E Sol\u00e0","year":"2018","unstructured":"Sol\u00e0 E, Sol\u00e9 C, Sim\u00f3n-Talero M, Mart\u00edn-Llah\u00ed M, Castellote J, Garcia-Mart\u00ednez R, et al. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. J Hepatol. 2018;69:1250\u20131259","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10841-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10841-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10841-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:48:57Z","timestamp":1759949337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10841-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10841"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10841-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anand V. Kulkarni, Rakhi Maiwall, Vinod Arora, Ankur Jindal, Sherin Thomas, Rehmat Ali, Sukriti Baweja, Ankit Bhardwaj, Guresh Kumar, Shiv Kumar Sarin have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical clearance"}},{"value":"NCT03144713.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinicaltrial.gov identifier"}}]}}